04 Sep Accuray builds on TomoTherapy’s talents in Madison
When a homegrown Madison tech company is acquired, it’s always hard to predict whether the local operations and jobs will survive — regardless of the promises made when the deal goes through.
In the case of TomoTherapy, though, not only has production continued here, it has grown.
Five years after the Madison medical device company was acquired in June 2011 by Accuray, of Sunnyvale, California, for $277 million, the combined radiation oncology company has taken several big steps:
Two major updates of the TomoTherapy system have been released: the H series in 2012 and the Radixact system, just approved by the U.S. Food and Drug Administration in June 2016 and the European Union in August.
Sorry, the comment form is closed at this time.